|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.570 AUD | +2.80% |
|
+3.21% | -5.51% |
| 02-09 | Mesoblast Says JPMorgan Chase Becomes Substantial Holder; Shares Rise 6% | MT |
| 02-06 | ASX Biggest Losers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.28B | - | ||||
| 47.36B | |||||
| 39.11B | |||||
| 34.2B | |||||
| 30.94B | |||||
| 18.55B | - | - | - | - | - |
- Stock Market
- Equities
- MSB Stock
- Charts Mesoblast Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition